Don’t put off your health. We’re available for in-person or telehealth appointments.
In response to the COVID-19 health issue, we are offering telehealth as well as in-person appointments. Click to learn more.
Marcus Brooks, is an example of early detection as the best defense against prostate cancer. Screenings are critical, despite COVID concerns.
Cases may go undetected longer due to delayed screenings. This puts African Americans at an even greater risk for prostate cancer.
Approximately 150 frontline workers at The Urology Group received their first dose of the COVID-19 vaccination on January 15, 2021.
View All News Releases
Dr. Michael Rousseau of The Urology Group has achieved a high level of training and experience with the UroLift® System to care for men with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.
The Urology Group is proud to announce that it has earned URAC accreditation in Specialty Pharmacy.
URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement, and innovation.
Nearly 1,000 runners will be in place when the starting bell rings Sept. 14 at Belterra Park Cincinnati for the Gentlemen Stakes For Prostate Cancer 5K Run/Walk. The charity race is sponsored by The Urology Group and benefits ZERO – The End of Prostate Cancer.
View All Press Releases
We welcome the media to contact us for interviews with our physicians and leadership team on a variety of healthcare topics. Learn more about The Urology Group by clicking on this At-A-Glance sheet or by reading our 2016 Anniversary Report.
|Robin Brinck||Carol Bross-McMahon|
|(513) 841-7488||(513) 673-2720|